BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 19 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $227,117 | -29.4% | 11,305 | -10.4% | 0.00% | – |
| Q2 2023 | $321,858 | +8.9% | 12,612 | -9.2% | 0.00% | – |
| Q1 2023 | $295,483 | -22.9% | 13,892 | +7.3% | 0.00% | – |
| Q4 2022 | $383,084 | -42.1% | 12,942 | -54.5% | 0.00% | – |
| Q3 2022 | $662,000 | +203.7% | 28,475 | +119.6% | 0.00% | – |
| Q2 2022 | $218,000 | -44.0% | 12,966 | +45.9% | 0.00% | – |
| Q1 2022 | $389,000 | +620.4% | 8,884 | +896.0% | 0.00% | – |
| Q4 2021 | $54,000 | +54.3% | 892 | +5.4% | 0.00% | – |
| Q3 2021 | $35,000 | -32.7% | 846 | -50.7% | 0.00% | – |
| Q2 2021 | $52,000 | +372.7% | 1,715 | +387.2% | 0.00% | – |
| Q1 2021 | $11,000 | +175.0% | 352 | +50.4% | 0.00% | – |
| Q4 2020 | $4,000 | -55.6% | 234 | -52.7% | 0.00% | – |
| Q3 2020 | $9,000 | -75.0% | 495 | -78.3% | 0.00% | – |
| Q2 2020 | $36,000 | +111.8% | 2,285 | +33.0% | 0.00% | – |
| Q2 2019 | $17,000 | – | 1,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
| Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
| First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
| Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
| HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
| BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
| DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
| Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |